These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26106934)

  • 1. Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists.
    Vaduganathan M; Mentz RJ; Greene SJ; Senni M; Sato N; Nodari S; Butler J; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2015; 13(7):799-809. PubMed ID: 26106934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolvaptan in Patients Hospitalized With Acute Heart Failure: Rationale and Design of the TACTICS and the SECRET of CHF Trials.
    Felker GM; Mentz RJ; Adams KF; Cole RT; Egnaczyk GF; Patel CB; Fiuzat M; Gregory D; Wedge P; O'Connor CM; Udelson JE; Konstam MA
    Circ Heart Fail; 2015 Sep; 8(5):997-1005. PubMed ID: 26374918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?
    Masoumi A; Ortiz F; Radhakrishnan J; Schrier RW; Colombo PC
    Heart Fail Rev; 2015 May; 20(3):283-90. PubMed ID: 25447845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.
    Goldsmith SR; Burkhoff D; Gustafsson F; Voors A; Zannad F; Kolkhof P; Staedtler G; Colorado P; Dinh W; Udelson JE
    J Card Fail; 2021 Feb; 27(2):233-241. PubMed ID: 33188886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational use of diuretics in acute decompensated heart failure.
    Goebel JA; Van Bakel AB
    Curr Heart Fail Rep; 2008 Sep; 5(3):153-62. PubMed ID: 18752765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolvaptan for Volume Management in Heart Failure.
    Gunderson EG; Lillyblad MP; Fine M; Vardeny O; Berei TJ
    Pharmacotherapy; 2019 Apr; 39(4):473-485. PubMed ID: 30802995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full decongestion in acute heart failure therapy.
    Buttar C; Alai H; Matanes FN; Cassidy MM; Stencel J; Le Jemtel TH
    Am J Med Sci; 2024 Sep; 368(3):182-189. PubMed ID: 38880301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of vasopressin receptor antagonists in heart failure resulting in hospitalization.
    De Luca L; Orlandi C; Udelson JE; Fedele F; Gheorghiade M
    Am J Cardiol; 2005 Dec; 96(12A):24L-33L. PubMed ID: 16399090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in heart failure: the role of arginine vasopressin and diuretics.
    Rosner MH
    Cardiovasc Drugs Ther; 2009 Aug; 23(4):307-15. PubMed ID: 19554441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Tolvaptan in Congestive Heart Failure Patients with and Without Hypoalbuminemia: A Pilot Study.
    Okabe T; Yakushiji T; Igawa W; Ono M; Kido T; Ebara S; Yamashita K; Yamamoto MH; Saito S; Hoshimoto K; Amemiya K; Isomura N; Araki H; Ochiai M
    Cardiovasc Ther; 2015 Oct; 33(5):275-81. PubMed ID: 26122275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel diuretic strategies for the treatment of heart failure in Japan.
    Dohi K; Ito M
    Circ J; 2014; 78(8):1816-23. PubMed ID: 25008484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to treatment of acute heart failure.
    Goldsmith SR
    J Cardiol; 2016 May; 67(5):395-8. PubMed ID: 26946929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics.
    Costello-Boerrigter LC; Boerrigter G; Burnett JC
    Med Clin North Am; 2003 Mar; 87(2):475-91. PubMed ID: 12693735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
    [No Abstract]   [Full Text] [Related]  

  • 18. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents.
    Tamargo J; Segura J; Ruilope LM
    Expert Opin Pharmacother; 2014 Apr; 15(5):605-21. PubMed ID: 24456327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
    Rossignol P; Dobre D; McMurray JJ; Swedberg K; Krum H; van Veldhuisen DJ; Shi H; Messig M; Vincent J; Girerd N; Bakris G; Pitt B; Zannad F
    Circ Heart Fail; 2014 Jan; 7(1):51-8. PubMed ID: 24297687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.